Fifty-five life scientists from Europe and around the world, on 9 May 2012 in Heidelberg, Germany, were recognised by EMBO (Excellence in Life Sciences) for their excellence in research. Forty-eight of the researchers are from Europe and neighbouring countries while seven scientists from Argentina, Australia, South Korea and the United States join as Associate Members. In total, EMBO membership now comprises almost 1,550 life scientists in the international scientific community.
EMBO elects new members annually on the basis of scientific excellence. The new members represent a broad cross-section of the life sciences. The latest scientists to join the group come from 17 different countries and include 13 female scientists recognized for their contributions to life science research.
The new Associate Member from Australia is professor David L. Vaux, Walter and Eliza Hall Institute, Parkville. Prof. Vaux is best known for identifying the proto-oncogene bcl-2 as an inhibitor of cell death, thus launching the field of molecular biology of apoptosis (programmed cell death). Read more about his research division Cell Signalling and Cell Death and his research overview, interests, and selected publications.
The selected researchers will help shape the direction of the life sciences in Europe and beyond by their involvement with the activities of the organization. EMBO Members provide scientific input such as acting on advisory editorial boards of the four scientific journals of the organization, serving on selection committees for EMBO Programmes and giving general advice to the scientific community.